Brief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
13/10/2026 14:23
BRIEF-Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited Oct 13 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS:
LAL PATHLABS- UNIT ACQUIRED REMAINING 30% EQUITY STAKE IN CENTRAPATH LABS PRIVATE LIMITED
LAL PATHLABS- ACQUIRED 30% EQUITY OF CPL AT 1608.35 RUPEES PER SHARE
Source text: ID:nBSERlrRb
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise